Healthcare information systems developer Clinical Computing is cancelling its Aim quotation on 1 May.
The shares will be traded on Britdaq, which is an appointed representative of Walker Crips Stockbrokers. Britdaq also matches bargains in former Aim companies Freshwater UK, Getmapping and Rock Solid Images. Clinical previously said that JP Jenkins would match bargains.
A lack of liquidity and inability to raise additional cash are given as reasons to leave Aim. This should save £80,000 a year.
Clinical is loss-making, although R&D tax credits put it into profit after tax.
Despite the departure from Aim, JM Finn has increased its stake to more than 5%.
At 0.62p a share, Clinical is valued at £690,000.
Download the latest AIM Journal from http://www.hubinvest.com/AIMPDFApril2012_31.pdf
© 2021 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.